RecruitingNCT06967311
Human and Microbial Determinants of the Onset of IBD Flares
Microbial and Human Determinants of the Onset of IBD Flares
Sponsor
Viome
Enrollment
100 participants
Start Date
Jan 31, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study will collect longitudinal biological samples and survey data to identify the triggers of IBD flares.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with ibd (inflammatory bowel disease). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06967311
Related Trials
Individualizing Anti-TNF Therapy in Patients With Inflammatory Bowel Disease
NCT076441171 location
A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult
NCT076325731 location
Pre-Packaged Low-Residue Diet Assisting Bowel Preparation in Patients With Inflammatory Bowel Disease
NCT071654702 locations
Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease
NCT073538531 location
Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients
NCT073357051 location